Clinical studies recruiting near Pretoria

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 7100003 · Sanofi · NCT06867094 Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Phase 2 · Setshaba Research Center · Gates Medical Research Institute · NCT07525427 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Netcare Pretoria East Hospital-Alberts Cellular Therapy ( Si · Merck Sharp & Dohme LLC · NCT06136559 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Univ. Pretoria and Steve Biko Academic Hospitals ( Site 2804 · Merck Sharp & Dohme LLC · NCT07216703 A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
Phase 3 · Setshaba Research Centre ( Site 0252) · Merck Sharp & Dohme LLC · NCT07044297 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone
Phase 3 · Celgene · NCT05519085 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 90098 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Steve Biko Academic Hospital /ID# 230883 · AbbVie · NCT04928846 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · Alberts Cellular Therapy · Takeda · NCT06499285 A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
Phase 3 · Wilgers Oncology Centre · Pfizer · NCT06629779 A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients
Phase 2 · Clinical Research Unit, University of Pretoria, Room 2-54, P · Elevara Medicines Limited · NCT07409103 A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Sta
Phase 3 · Life Groenkloof · Bristol-Myers Squibb · NCT06561386 A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Sin
Phase 3 · Setshaba Research Centre · Pfizer · NCT06866405 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants Wi
Phase 3 · Research Site · AstraZeneca · NCT05211895 Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)
Phase 3 · Steve Biko Academic Hospital, University of Pretoria · Population Health Research Institute · NCT05580666 EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Ye
Phase 3 · Botho Ke Bontle Health Services · Pfizer · NCT05261139 A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Comp
Phase 3 · Research Site · AstraZeneca · NCT07662044 Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIR
Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT06133972 A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R)
Phase 3 · Alberts Cellular Therapy. ( Site 4401) · Merck Sharp & Dohme LLC · NCT05947851 Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in
Phase 3 · Wilgers Oncology Centre ( Site 2006) · Merck Sharp & Dohme LLC · NCT03486873 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Steve Biko Academic Hospital · Hoffmann-La Roche · NCT05894239 Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Dee
Phase 3 · Anthos Investigative Site 2402 · Anthos Therapeutics, Inc. · NCT05712200 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Treponemal Shedding, Load, and Viability, in Women and Men-who-have-sex-with-women-only With Early Infectious Syphilis:
Phase N/A · Foundation for Professional Development · Monash University · NCT07300254 A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to
Phase 3 · Site 123001 · mAbxience Research S.L. · NCT06687369 A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Tr
Phase 3 · Curo Oncology ( Site 2908) · Merck Sharp & Dohme LLC · NCT06312176 A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urt
Phase 3 · Global Clinical Trials (Pty) Ltd · Celldex Therapeutics · NCT07266402 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Medicross Pretoria West, Jongaie Research · Hoffmann-La Roche · NCT05878769

Look up another city

Look up another condition